Japan ticks Gropep mix
Thursday, 21 April, 2005
Adelaide biopharma GroPep has announced that a Japanese biopharmaceutical company has received regulatory approval in Japan to manufacture a biopharmaceutical product containing one of GroPep's products.
GroPep said commercial secrecy prevented it naming the ingredient, the company, or the product, but it is the sixth biopharmaceutical product containing GroPep's proprietary cell-culture products to receive regulatory approval.
It's not going to be a big source of revenue, but GroPep said the Japanese product is currently undergoing clinical trials for several other indications, some of which have multi-billion global markets.
CEO Bob Finder said the Japanese approval reinforced growing international recognition of the superiority of GroPep's cell culture products for the manufacture of certain biopharmaceutical products.
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
Space conditions can lead to periodontitis, scientists say
Living in zero gravity can lead to periodontitis — a serious condition where the gums...
Personalised brain stimulation helps treat those with depression
By tailoring transcranial magnetic stimulation to each person's unique brain structure,...